Kim L. O'Neill

}}

'''Kim L. O'Neill''' is the developer of a monoclonal antibody that allows for the accurate, cheap and easy detection of cancer.

O'Neill has a B.Sc. degree from New University of Ulster and a Ph.D. from the University of Ulster. He is a full professor of microbiology at Brigham Young University. In 1998 research by O'Neill suggested a link between caffeine and the formation of some cancers. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'Kim L. O'Neill', query time: 0.01s Refine Results
  1. 1
    Chimeric autoantibody receptor T cells specifically eliminate Graves’ Disease autoreactive B cells

    Chimeric autoantibody receptor T cells specifically eliminate Graves’ Disease autoreactive B cells by Abigail Cheever, Hunter G. Lindsay, Chloe C. Kang, Mackenzie Hansen, Kimball Demars, Kim L. O’Neill, K. Scott Weber

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Cytotoxicity of Atriplex confertifolia

    Cytotoxicity of Atriplex confertifolia by Christopher J. Capua, Nick P. Hopson, C. Malcolm M. Stewart, G. Robert Johnston, Kim L. O'Neill, G. Bruce Schaalje, Christopher M. Lee, Gary M. Booth

    Published 2010-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: